Skip to Main Content

Paper Details

Discordant responses of plasma low-density lipoprotein cholesterol and lipoprotein(a) to alirocumab: A pooled analysis from 10 ODYSSEY Phase 3 studies.
Eur J Prev Cardiol
11
2021
Author NameAffiliation
Jessica MinnierOregon Health & Science University, Knight Cardiovascular Institute, Center for Preventive Cardiology
Jessica MinnierOregon Health & Science University, OHSU-PSU School of Public Health
Michael D ShapiroCenter for Preventive Cardiology, Wake Forest University Baptist Medical Center
  • 1 - 3

Datasets

Release 1.2